01.03.2022 Views

CLINICAL LAB SCIENEC

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CHAPTER 12: PROCEDURES FOR URINALYSIS AND BODY FLUIDS 313

5. Drop 1 Clinitest tablet into the test tube containing

the water and urine (or fecal) sample.

When a fecal sample is used, refer to

the collection procedures described under

the principles section for this procedure.

a. Watch for a boiling reaction.

b. Do not shake the tube during the reaction

or for 15 seconds after the boiling

stops.

c. Remember to watch for what is called

the “pass-through phenomenon.” This

action is defined as a series of color

reactions over a period of time until the

end-point occurs.

6. Determine results of the procedure from the

chart provided with the manufacturer’s kit.

7. Discard all supplies used for the procedure

in the appropriate containers. A disinfectant

should be used to clean the work

surfaces and equipment should be cleaned

and restored to its former position. Gloves

should be discarded appropriately and the hands washed thoroughly in accordance

with established policies.

Reporting of Results

Record the semiquantitative results on the Procedure Report Form or other appropriate

form as follows:

0 Trace ½% 1% 2% 3% 5%

0 trace 1 /2% 1% 2% 3% 5%

FIGURE 12-37 Performing Clinitest by placing 5 drops of urine

into test tube.

Source: Delmar/Cengage Learning.

URINALYSIS AND BODY FLUIDS ANALYSIS PROCEDURE #6

Confirmatory Semiquantitative Test for Total Protein in Urine

Principles

Measurement of urinary proteins is becoming increasingly important in the detection

of renal pathology. Proteinuria (increased amounts of protein in urine) can occur

in increased glomerular permeability, defective tubular reabsorption, and

abnormal secretion of protein into the urinary tract. Proteinuria can also be transient,

during cases of urinary tract infection or severe stress. Albuminuria (increased

albumin in urine) has been implicated as an early indicator of renal damage in diabetes

that can be reversed if identified and treated sufficiently early. Measurement

of total protein and specific proteins in cerebrospinal fl uid (CSF) is used to detect

increased permeability of the blood–brain barrier.

Often it is necessary to measure components of urine that may be positive when

screened by a dipstick, as certain conditions may yield a false positive. These confirmatory

tests can be time consuming but should be performed to avoid unnecessary

Copyright 2010 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).

Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!